The approval of the Mynx Control venous vascular closure device is based on the results of the ReliaSeal trial, which demonstrated a 100% procedure and device success rate in cardiac ablation procedures.
FDA Approves Cordis Vascular Closure Device for Cardiac Ablation Procedures
Leave a Comment
